| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.1 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.22 | 0.1 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.1 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.049 | 0.1 |